Article
Similarities in the Neuropathy Phenotype of Cancer Survivors Who Received Different Classes of Chemotherapy Drugs.
The journal of pain - 1 Sept 2022
Miaskowski Christine, Levine Jon D, Paul Steven M, Cooper Bruce, Abrams Gary, Topp Kimberly, Cheung Steven, Henderson-Sabes Jennifer, Conley Yvette P, Snowberg Karin, Alfaro Emely, Quinn Marisa, Kober Kord M
Abstract excerpt
With the advent of platinum and taxane compounds used as single agents or in combination regimens, survival rates for some of the most common cancers have improved substantially. However, information on differences in the chemotherapy-induced peripheral neuropathy (CIPN) phenotype among single and combination regimens is limited. Study's purposes were to evaluate for differences in demographic and clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.